These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 21615950

  • 1. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.
    Zhou Q, Dalgard CL, Wynder C, Doughty ML.
    BMC Neurosci; 2011 May 26; 12():50. PubMed ID: 21615950
    [Abstract] [Full Text] [Related]

  • 2. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
    Newbold A, Salmon JM, Martin BP, Stanley K, Johnstone RW.
    Oncogene; 2014 Nov 20; 33(47):5415-23. PubMed ID: 24292681
    [Abstract] [Full Text] [Related]

  • 3. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.
    Mathew OP, Ranganna K, Yatsu FM.
    Biomed Pharmacother; 2010 Dec 20; 64(10):733-40. PubMed ID: 20970954
    [Abstract] [Full Text] [Related]

  • 4. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
    Hrgovic I, Doll M, Kleemann J, Wang XF, Zoeller N, Pinter A, Kippenberger S, Kaufmann R, Meissner M.
    BMC Cancer; 2016 Sep 30; 16(1):763. PubMed ID: 27716272
    [Abstract] [Full Text] [Related]

  • 5. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1.
    Gui CY, Ngo L, Xu WS, Richon VM, Marks PA.
    Proc Natl Acad Sci U S A; 2004 Feb 03; 101(5):1241-6. PubMed ID: 14734806
    [Abstract] [Full Text] [Related]

  • 6. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
    Chen S, Zhao Y, Gou WF, Zhao S, Takano Y, Zheng HC.
    PLoS One; 2013 Feb 03; 8(11):e79781. PubMed ID: 24236158
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.
    Findeisen HM, Gizard F, Zhao Y, Qing H, Heywood EB, Jones KL, Cohn D, Bruemmer D.
    Arterioscler Thromb Vasc Biol; 2011 Apr 03; 31(4):851-60. PubMed ID: 21233448
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
    Richon VM, Sandhoff TW, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 2000 Aug 29; 97(18):10014-9. PubMed ID: 10954755
    [Abstract] [Full Text] [Related]

  • 9. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
    Xue K, Gu JJ, Zhang Q, Mavis C, Hernandez-Ilizaliturri FJ, Czuczman MS, Guo Y.
    J Cancer Res Clin Oncol; 2016 Feb 29; 142(2):379-87. PubMed ID: 26314218
    [Abstract] [Full Text] [Related]

  • 10. Histone deacetylase inhibitors selectively suppress expression of HDAC7.
    Dokmanovic M, Perez G, Xu W, Ngo L, Clarke C, Parmigiani RB, Marks PA.
    Mol Cancer Ther; 2007 Sep 29; 6(9):2525-34. PubMed ID: 17876049
    [Abstract] [Full Text] [Related]

  • 11. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F, Guerra F, Pession A, Ferreri AM.
    Oncol Rep; 2005 Jun 29; 13(6):1139-44. PubMed ID: 15870934
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
    Hsieh YH, Su IJ, Yen CJ, Tsai TF, Tsai HW, Tsai HN, Huang YJ, Chen YY, Ai YL, Kao LY, Hsieh WC, Wu HC, Huang W.
    Carcinogenesis; 2013 Feb 29; 34(2):475-85. PubMed ID: 23172669
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair.
    Lee JH, Choy ML, Ngo L, Foster SS, Marks PA.
    Proc Natl Acad Sci U S A; 2010 Aug 17; 107(33):14639-44. PubMed ID: 20679231
    [Abstract] [Full Text] [Related]

  • 14. A novel suberoylanilide hydroxamic acid histone deacetylase inhibitor derivative, N25, exhibiting improved antitumor activity in both human U251 and H460 cells.
    Zhang S, Huang WB, Wu L, Wang LY, Ye LB, Feng BH.
    Asian Pac J Cancer Prev; 2014 Aug 17; 15(10):4331-8. PubMed ID: 24935393
    [Abstract] [Full Text] [Related]

  • 15. Cell Cycle Arrest and Cytotoxic Effects of SAHA and RG7388 Mediated through p21WAF1/CIP1 and p27KIP1 in Cancer Cells.
    Natarajan U, Venkatesan T, Radhakrishnan V, Samuel S, Rasappan P, Rathinavelu A.
    Medicina (Kaunas); 2019 Jan 29; 55(2):. PubMed ID: 30700046
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells.
    Laurenzana A, Balliu M, Cellai C, Romanelli MN, Paoletti F.
    PLoS One; 2013 Jan 29; 8(3):e58267. PubMed ID: 23469273
    [Abstract] [Full Text] [Related]

  • 17. Histone deacetylase inhibitor (HDACi) upregulates activin A and activates the Smad signaling pathway in melanomas.
    Lee J, Ko J, Yi JY.
    J Dermatol Sci; 2018 Apr 29; 90(1):13-20. PubMed ID: 29290529
    [Abstract] [Full Text] [Related]

  • 18. p21(Waf1) is required for cellular senescence but not for cell cycle arrest induced by the HDAC inhibitor sodium butyrate.
    Romanov VS, Abramova MV, Svetlikova SB, Bykova TV, Zubova SG, Aksenov ND, Fornace AJ, Pospelova TV, Pospelov VA.
    Cell Cycle; 2010 Oct 01; 9(19):3945-55. PubMed ID: 20935470
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells.
    Mateen S, Raina K, Jain AK, Agarwal C, Chan D, Agarwal R.
    Epigenetics; 2012 Oct 01; 7(10):1161-72. PubMed ID: 22965008
    [Abstract] [Full Text] [Related]

  • 20. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM, Roth DM, Marchal C, Bouchecareilh M.
    Methods Mol Biol; 2017 Oct 01; 1510():77-91. PubMed ID: 27761814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.